Replies to post #16992 on Amarin Corp Plc (AMRN)

[exwannabe]

So the interesting part is the answer and question time between the panel and amrn team ?

No, it is a long open discussion by the panel and both the FDA and AMRN will be asked questions by the panel.

To be clear, the panel is not the FDA.

The agenda is:
. AMRN presents, then maybe a few questions by the panel.
. FDA presents, then maybe a few questions by the panel.
. lunch break
. A lot of boring talk by "the public".
. The panel discusses the issues and asks Qs of both the FDA and AMRN
. The vote

It is that next to last step where it gets interesting. In this case, the discussion might mean more than the vote.